HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xuelian Wei Selected Research

Tablets

1/2019Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial.
3/2014A randomized, double-blind comparison of single-tablet regimen elvitegravir/cobicistat/emtricitabine/tenofovir DF vs ritonavir-boosted atazanavir plus emtricitabine/tenofovir DF for initial treatment of HIV-1 infection: analysis of week 144 results.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xuelian Wei Research Topics

Disease

8Infections
05/2024 - 06/2012
3Nausea
11/2020 - 11/2017
2Weight Gain
10/2021 - 12/2020
2COVID-19
01/2021 - 11/2020
2Headache (Headaches)
01/2019 - 01/2019
2Hepatitis B
01/2019 - 11/2017
1Bacterial Infections (Bacterial Infection)
05/2024
1Hemorrhage
05/2024
1Inflammation (Inflammations)
05/2024
1Wounds and Injuries (Trauma)
05/2024
1IGA Glomerulonephritis (IGA Nephropathy)
03/2024
1Proteinuria
03/2024
1Neoplasms (Cancer)
12/2023
1Atherosclerosis
12/2023
1Severe Acute Respiratory Syndrome
01/2021
1Constipation
11/2020
1Respiratory Insufficiency (Respiratory Failure)
11/2020
1Pulmonary Embolism
01/2019
1Lymphoma (Lymphomas)
01/2019
1Heart Failure
01/2019
1Chronic Hepatitis B
01/2019
1Heart Diseases (Heart Disease)
01/2019
1Heart Arrest (Cardiac Arrest)
01/2019
1Osteoporosis
01/2019
1Adenocarcinoma
01/2019
1Urticaria (Hives)
01/2017
1Hypertension (High Blood Pressure)
04/2016

Drug/Important Bio-Agent (IBA)

7Emtricitabine (Emtriva)FDA Link
01/2019 - 06/2012
6Tenofovir (Viread)FDA Link
12/2020 - 06/2012
5tenofovir alafenamideIBA
12/2020 - 01/2017
5dolutegravirIBA
12/2020 - 01/2017
5bictegravirIBA
12/2020 - 01/2017
4abacavir (Ziagen)FDA Link
10/2021 - 11/2017
3RNA (Ribonucleic Acid)IBA
01/2021 - 11/2017
3elvitegravirIBA
12/2020 - 04/2013
3CobicistatIBA
12/2020 - 04/2013
3Ritonavir (Norvir)FDA Link
03/2014 - 06/2012
3Atazanavir Sulfate (Reyataz)FDA Link
03/2014 - 06/2012
2EnzymesIBA
12/2023 - 01/2021
2NucleosidesIBA
01/2021 - 12/2020
2remdesivirIBA
01/2021 - 11/2020
2Protease Inhibitors (Protease Inhibitor)IBA
12/2020 - 06/2012
2Antiviral Agents (Antivirals)IBA
11/2020 - 01/2019
2TabletsIBA
01/2019 - 03/2014
2Lamivudine (Epivir)FDA Link
01/2019 - 11/2017
2HLA-B Antigens (HLA-B)IBA
01/2019 - 11/2017
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2024
1vanillinIBA
05/2024
1CollagenIBA
05/2024
1HydrogelsIBA
05/2024
1TACI receptor-IgG Fc fragment fusion proteinIBA
03/2024
1factor AIBA
03/2024
1Proteins (Proteins, Gene)FDA Link
03/2024
1galactosyl-deficient IgA1IBA
03/2024
1LigandsIBA
03/2024
1CopperIBA
12/2023
1ceric oxide (cerium dioxide)IBA
12/2023
1AntioxidantsIBA
12/2023
1GS-441524 triphosphateIBA
01/2021
1triphosphoric acid (triphosphate)IBA
01/2021
1Zidovudine (Retrovir)FDA LinkGeneric
12/2020
1Rilpivirine (TMC-278)IBA
12/2020
1efavirenz (Sustiva)FDA Link
12/2020
1Reverse Transcriptase InhibitorsIBA
12/2020
1IntegrasesIBA
12/2020
1NucleotidesIBA
12/2020
1Alanine Transaminase (SGPT)IBA
11/2020
1DNA-Directed RNA Polymerases (RNA Polymerase)IBA
11/2020
1GlucocorticoidsIBA
01/2019
1LuteolinIBA
01/2019
1CreatinineIBA
04/2016
1RacivirIBA
06/2012
1Tenofovir Disoproxil Fumarate Drug Combination Emtricitabine Cobicistat ElvitegravirIBA
06/2012

Therapy/Procedure

5Therapeutics
12/2023 - 06/2012
2Art Therapy
10/2021 - 12/2020
1Artificial Respiration (Mechanical Ventilation)
11/2020